The EXCEL Trial: The Interventionalists’ Perspective
Left main stem (LMS) disease is identified in up to 5% of diagnostic angiography cases, and is associated with significant morbidity and mortality due to the proportion of myocardium it subtends. In the past 10 years, there has been a significant change in the way we contemplate treating lesions in...
Guardado en:
Autores principales: | George William Hunter, Vinoda Sharma, Chetan Varma, Derek Connolly |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1a821c0da314a6389592702409044bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The ISCHEMIA Trial: What is the Message for the Interventionalist?
por: Emmanuel Ako, et al.
Publicado: (2021) -
The EXCEL Trial: The Surgeons’ Perspective
por: Marjan Jahangiri, et al.
Publicado: (2020) -
Editorial: The EXCEL Trial
por: Pablo Avanzas, et al.
Publicado: (2021) -
What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
por: Robert Sykes, et al.
Publicado: (2021) -
Pharmacotherapy in Stable Coronary Artery Disease: Historical Perspectives and New Insights from the ISCHEMIA Trial
por: Jonathan Yap, et al.
Publicado: (2021)